Kaufmann AM - Search Results

1

Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years.

Deleré Y, Schuster M, Vartazarowa E, Hänsel T, Hagemann I, Borchardt S, Perlitz H, Schneider A, Reiter S, Kaufmann AM. Deleré Y, et al. Among authors: kaufmann am. J Clin Microbiol. 2011 Oct;49(10):3519-22. doi: 10.1128/JCM.01026-11. Epub 2011 Aug 3. J Clin Microbiol. 2011. PMID: 21813722 Free PMC article.

2

[HPV infection and cervical carcinoma--epidemiology, detection and immunology].

Schneider A, Dürst M, Kaufmann AM. Schneider A, et al. Among authors: kaufmann am. Zentralbl Gynakol. 2001 Apr;123(4):179-85. doi: 10.1055/s-2001-14774. Zentralbl Gynakol. 2001. PMID: 11370524 Review. German.

3

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Kaufmann AM, Stern PL, Rankin EM, Sommer H, Nuessler V, Schneider A, Adams M, Onon TS, Bauknecht T, Wagner U, Kroon K, Hickling J, Boswell CM, Stacey SN, Kitchener HC, Gillard J, Wanders J, Roberts JS, Zwierzina H. Kaufmann AM, et al. Clin Cancer Res. 2002 Dec;8(12):3676-85. Clin Cancer Res. 2002. PMID: 12473576

4

HPV induced cervical carcinogenesis: molecular basis and vaccine development.

Kaufmann AM, Backsch C, Schneider A, Dürst M. Kaufmann AM, et al. Zentralbl Gynakol. 2002 Nov;124(11):511-24. doi: 10.1055/s-2002-39579. Zentralbl Gynakol. 2002. PMID: 12796844 Review.

5

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.

Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Dürst M, Kaufmann AM. Nonn M, et al. Among authors: kaufmann am. J Cancer Res Clin Oncol. 2003 Sep;129(9):511-20. doi: 10.1007/s00432-003-0462-6. Epub 2003 Aug 2. J Cancer Res Clin Oncol. 2003. PMID: 12905010

6

An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.

Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM. Ohlschläger P, et al. Among authors: kaufmann am. Vaccine. 2006 Apr 5;24(15):2880-93. doi: 10.1016/j.vaccine.2005.12.061. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16472545

7

New paradigm for prevention of cervical cancer.

Kaufmann AM, Schneider A. Kaufmann AM, et al. Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):25-9. doi: 10.1016/j.ejogrb.2006.07.048. Epub 2006 Sep 14. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16973254

8

HPV testing in the follow-up after treatment of women with CIN.

von Keyserling H, Kaufmann AM, Schneider A. von Keyserling H, et al. Among authors: kaufmann am. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S5-7. doi: 10.1016/j.ygyno.2007.07.048. Epub 2007 Aug 31. Gynecol Oncol. 2007. PMID: 17764728 No abstract available.

9

[Implementation of HPV vaccination in Germany].

Schreckenberger C, Kaufmann AM, Schneider A. Schreckenberger C, et al. Among authors: kaufmann am. Dtsch Med Wochenschr. 2007 Oct;132(42):2221-4. doi: 10.1055/s-2007-991634. Dtsch Med Wochenschr. 2007. PMID: 17926251 German. No abstract available.

10

Should all women be vaccinated against HPV?

Schmitt HJ, Kaufmann AM, Schneider A. Schmitt HJ, et al. Among authors: kaufmann am. Pol Arch Med Wewn. 2007 Oct;117(10):448-51. Pol Arch Med Wewn. 2007. PMID: 18320785 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters